On January 3, 2024, a delegation from the Hebei Tsinghua Development Research Institute visited the Cangzhou Lingang Economic Development Zone in Hebei. They conducted comprehensive research at both the Chemical Pharmaceutical Research and Development Public Experimental Platform and Laviana Pharma's Cangzhou GMP Production Plant. During the visit, leaders from both sides engaged in extensive discussions on promoting high-quality development in the biopharmaceutical industry within the Beijing-Tianjin-Hebei region.

Recently, Laviana Pharma Cangzhou GMP production center successfully passed the ISO 9001:2015 Quality Management System Certification. The certification marks that the Laviana Pharma Cangzhou GMP production center has entered the track of enterprise management featuring standardization, programming, and normalization. It also means the production center has reached the international standard in terms of quality management system, which provides a strong guarantee for the sustainable development.

On October 26, 2023, the three-day CPHI Barcelona 2023 came to an end at the Fira de Barcelona in Barcelona, Spain. CPHI Barcelona 2023, the world’s largest trade fair for the pharmaceutical industry, gathers industry-leading biopharmaceutical companies, investors and collaborators from all over the world, and many collaborative activities are held during the event.

On September 8, 2023, the 2023 Chem Outsourcing was successfully concluded at Hilton Parsippany in New Jersey. The executive and business teams of Laviana Pharma were invited to participate in this event, and they shared Laviana Pharma's latest R&D achievements, cutting-edge technologies with industry colleagues from around the world, receiving widespread attention and praise.

Recently, Laviana Pharma successfully passed the annual audit and CNAS expansion (Registration Number: CNAS L16763) to increase the scopes of many recognized tests as reviewed by the China National Accreditation Service for Conformity Assessment (CNAS), including pharmaceutical raw materials, intermediates and thermal safety testing of products, expanded to cover thermal safety testing of chemical products and pharmaceutical physicochemical testing. Among them, 1 test was expended in the thermal safety testing of chemical products, and 16 tests were expanded in the pharmaceutical physicochemical testing.

On June 21, 2023, the three-day CPHI China 2023 successfully concluded at Shanghai New International Expo Center in Pudong, Shanghai. Laviana Pharma, as a technology-driven, innovative pharmaceutical contract development and manufacturing organization (CDMO), was invited to attend the event.